dr aparna oncology limited
dr aparna oncology limited Company Information
Company Number
12623051
Website
-Registered Address
4 meliden way, penkhull, stoke on trent, staffordshire, ST4 5DZ
Industry
Specialist medical practice activities
Telephone
-
Next Accounts Due
February 2025
Group Structure
View All
Shareholders
prabha venkat 35%
vaikkun venkat 35%
View Alldr aparna oncology limited Estimated Valuation
Pomanda estimates the enterprise value of DR APARNA ONCOLOGY LIMITED at £158k based on a Turnover of £344.4k and 0.46x industry multiple (adjusted for size and gross margin).
dr aparna oncology limited Estimated Valuation
Pomanda estimates the enterprise value of DR APARNA ONCOLOGY LIMITED at £88.5k based on an EBITDA of £25.3k and a 3.5x industry multiple (adjusted for size and gross margin).
dr aparna oncology limited Estimated Valuation
Pomanda estimates the enterprise value of DR APARNA ONCOLOGY LIMITED at £220.2k based on Net Assets of £89k and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr Aparna Oncology Limited Overview
Dr Aparna Oncology Limited is a live company located in stoke on trent, ST4 5DZ with a Companies House number of 12623051. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in May 2020, it's largest shareholder is prabha venkat with a 35% stake. Dr Aparna Oncology Limited is a startup, micro sized company, Pomanda has estimated its turnover at £344.4k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dr Aparna Oncology Limited Health Check
Pomanda's financial health check has awarded Dr Aparna Oncology Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
5 Weak
Size
annual sales of £344.4k, make it in line with the average company (£354.3k)
- Dr Aparna Oncology Limited
£354.3k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Dr Aparna Oncology Limited
- - Industry AVG
Production
with a gross margin of 32.4%, this company has a higher cost of product (55.6%)
- Dr Aparna Oncology Limited
55.6% - Industry AVG
Profitability
an operating margin of 7.4% make it less profitable than the average company (13.4%)
- Dr Aparna Oncology Limited
13.4% - Industry AVG
Employees
with 3 employees, this is below the industry average (9)
- Dr Aparna Oncology Limited
9 - Industry AVG
Pay Structure
on an average salary of £29.6k, the company has an equivalent pay structure (£29.6k)
- Dr Aparna Oncology Limited
£29.6k - Industry AVG
Efficiency
resulting in sales per employee of £114.8k, this is more efficient (£73.1k)
- Dr Aparna Oncology Limited
£73.1k - Industry AVG
Debtor Days
it gets paid by customers after 101 days, this is later than average (34 days)
- Dr Aparna Oncology Limited
34 days - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is quicker than average (40 days)
- Dr Aparna Oncology Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dr Aparna Oncology Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Dr Aparna Oncology Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.2%, this is a lower level of debt than the average (31.7%)
13.2% - Dr Aparna Oncology Limited
31.7% - Industry AVG
DR APARNA ONCOLOGY LIMITED financials
Dr Aparna Oncology Limited's latest turnover from May 2023 is estimated at £344.4 thousand and the company has net assets of £89 thousand. According to their latest financial statements, we estimate that Dr Aparna Oncology Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2023 | May 2022 | May 2021 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2023 | May 2022 | May 2021 | |
|---|---|---|---|
| Tangible Assets | 6,897 | 2,720 | 3,628 |
| Intangible Assets | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 |
| Total Fixed Assets | 6,897 | 2,720 | 3,628 |
| Stock & work in progress | 0 | 0 | 0 |
| Trade Debtors | 95,589 | 91,428 | 15,919 |
| Group Debtors | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 |
| total current assets | 95,589 | 91,428 | 15,919 |
| total assets | 102,486 | 94,148 | 19,547 |
| Bank overdraft | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 |
| Trade Creditors | 12,780 | 23,414 | 9,067 |
| Group/Directors Accounts | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 |
| total current liabilities | 12,780 | 23,414 | 9,067 |
| loans | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| Accruals and Deferred Income | 725 | 725 | 725 |
| other liabilities | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 |
| total long term liabilities | 725 | 725 | 725 |
| total liabilities | 13,505 | 24,139 | 9,792 |
| net assets | 88,981 | 70,009 | 9,755 |
| total shareholders funds | 88,981 | 70,009 | 9,755 |
| May 2023 | May 2022 | May 2021 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | |||
| Amortisation | |||
| Tax | |||
| Stock | 0 | 0 | 0 |
| Debtors | 4,161 | 75,509 | 15,919 |
| Creditors | -10,634 | 14,347 | 9,067 |
| Accruals and Deferred Income | 0 | 0 | 725 |
| Deferred Taxes & Provisions | 0 | 0 | 0 |
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | 0 | 0 | 0 |
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 |
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 |
dr aparna oncology limited Credit Report and Business Information
Dr Aparna Oncology Limited Competitor Analysis
Perform a competitor analysis for dr aparna oncology limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in ST4 area or any other competitors across 12 key performance metrics.
dr aparna oncology limited Ownership
DR APARNA ONCOLOGY LIMITED group structure
Dr Aparna Oncology Limited has no subsidiary companies.
Ultimate parent company
DR APARNA ONCOLOGY LIMITED
12623051
dr aparna oncology limited directors
Dr Aparna Oncology Limited currently has 3 directors. The longest serving directors include Dr Prabha Venkat (May 2020) and Dr Apurna Jegannathen (May 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Prabha Venkat | England | 29 years | May 2020 | - | Director |
| Dr Apurna Jegannathen | England | 56 years | May 2020 | - | Director |
| Mr Vaikkun Venkat | United Kingdom | 26 years | May 2020 | - | Director |
P&L
May 2023turnover
344.4k
+28%
operating profit
25.3k
0%
gross margin
32.4%
-11.79%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
89k
+0.27%
total assets
102.5k
+0.09%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
dr aparna oncology limited company details
company number
12623051
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
May 2020
age
4
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
May 2023
previous names
N/A
accountant
DBBK ACCOUNTANTS LTD
auditor
-
address
4 meliden way, penkhull, stoke on trent, staffordshire, ST4 5DZ
Bank
-
Legal Advisor
-
dr aparna oncology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr aparna oncology limited.
dr aparna oncology limited Companies House Filings - See Documents
| date | description | view/download |
|---|
